Australian firm Ramsey Healthcare have agreed to buy Elysium Healthcare for $1.03bn (£775m). The deal will add 72 mental healthcare focused sites to their portfolio and is rumoured to have been transacted at around 13-14X EBITDA.
As with The Huntercombe Group acquisition within The Montreux Healthcare Fund portfolio, mental healthcare services are seen as even more important with the current threats to mental wellbeing during and post the COVID 19 pandemic. For this reason, the government has committed an additional £2.3bn in 2023-2024.
Oliver Harris, Managing Partner, Montreux Capital Management (UK) stated: “Our investors are often curious about transactions in the market and this latest deal signals the ongoing strength of investing within the UK healthcare sector. This asset is a similar size to the group my team is endeavouring to build and demonstrates the appetite for businesses of this scale in the market and the types of attractive multiples that they trade at. Global investors will always pay a premium for high quality assets, particularly those that have demonstrated a strong track record during the pandemic.”